Neuberger Berman Group LLC Biogen Inc. Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Biogen Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 32,099 shares of BIIB stock, worth $5.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

32,099

Previous 31,506 1.88%

Holding current value

$5.07 Million

Previous $7.3 Million 14.8%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $112,118 - $140,422	593 Added 1.88%	32,099 $6.22 Million
Q2 2024 Nov 14, 2024	BUY	$190.52 - $236.72 $2.25 Million - $2.8 Million	11,810 Added 59.96%	31,506 $7.3 Million
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $2.25 Million - $2.8 Million	11,810 Added 59.96%	31,506 $7.3 Million
Q1 2024 Nov 14, 2024	SELL	$212.02 - $267.71 $571,817 - $722,013	-2,697 Reduced 12.04%	19,696 $4.25 Million
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $4.18 Million - $5.27 Million	19,696 New	19,696 $4.25 Million
Q4 2023 Nov 14, 2024	SELL	$222.59 - $267.94 $2.03 Million - $2.44 Million	-9,113 Reduced 28.92%	22,393 $5.79 Million
Q4 2023 Feb 09, 2024	BUY	$222.59 - $267.94 $504,388 - $607,152	2,266 Added 11.26%	22,393 $5.79 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $74 Million - $83.6 Million	-292,312 Reduced 93.56%	20,127 $5.17 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $6,881 - $7,951	-25 Reduced 0.01%	312,439 $89 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $2.8 Million - $3.2 Million	10,933 Added 3.63%	312,464 $86.9 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $26.2 Million - $31.9 Million	-103,962 Reduced 25.64%	301,531 $83.5 Million
Q3 2022 Nov 15, 2022	BUY	$194.69 - $268.46 $37.7 Million - $52 Million	193,812 Added 91.56%	405,493 $108 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $37.6 Million - $44.7 Million	200,289 Added 1758.15%	211,681 $43.2 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $94,947 - $119,628	490 Added 4.49%	11,392 $1.98 Million
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $673,551 - $865,612	3,008 Added 38.1%	10,902 $2.06 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $4,527 - $5,904	-16 Reduced 0.2%	7,894 $1.55 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $667,443 - $1.07 Million	2,577 Added 48.32%	7,910 $1.98 Million
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $113,700 - $133,206	468 Added 9.62%	5,333 $1.41 Million
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $497,563 - $748,956	-2,106 Reduced 30.21%	4,865 $1.16 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $701,375 - $809,825	-2,649 Reduced 27.54%	6,971 $1.98 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $813,744 - $1.08 Million	3,146 Added 48.59%	9,620 $2.55 Million
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $73,127 - $92,762	272 Added 4.39%	6,474 $2.05 Million
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $90,004 - $124,364	-409 Reduced 6.19%	6,202 $1.84 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $376,823 - $422,644	-1,733 Reduced 20.77%	6,611 $1.54 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $2.27 Million - $2.5 Million	-10,347 Reduced 55.36%	8,344 $1.95 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $24,271 - $37,963	112 Added 0.6%	18,691 $4.42 Million
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $683,996 - $866,354	-2,456 Reduced 11.68%	18,579 $5.59 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $171,116 - $223,772	583 Added 2.85%	21,035 $7.43 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $207,046 - $246,755	-804 Reduced 3.78%	20,452 $5.94 Million
Q1 2018 May 08, 2018	BUY	$260.13 - $367.91 $111,075 - $157,097	427 Added 2.05%	21,256 $5.82 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $1.79 Million - $2 Million	-5,815 Reduced 21.82%	20,829 $6.64 Million
Q3 2017 Nov 15, 2017	BUY	$281.15 - $329.69 $7.49 Million - $8.78 Million	26,644	26,644 $8.34 Million

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Biogen Inc. Transaction History